In reply: The cardiovascular risk associated with white coat hypertension itself is quite separate from the risk of treating white coat hypertension inappropriately.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
This letter has been prepared by members of the Ambulatory Blood Pressure Monitoring Consensus Committee of the National Heart Foundation and the High Blood Pressure Research Council of Australia.
Relevant disclosures provided in our original article (Med J Aust 2012; 197: 143-144; doi: 10.5694/mja11.11637).